Prolia 60 mg solution for injection in pre-filled syringe clinical trials
6 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
NAPO - Novel Approach for Oligospermia
This study, called NAPO, is looking into how a new medicine called Prolia might help men with male infertility, specifically those with a low sperm count. Researchers will compare Prolia to a dummy treatment to see if it improves sperm concentration.
For: Male infertilityDenmark - Ongoing, recruitingTherapeutic exploratory (Phase II)
NT-NOA - Novel Treatment of some men with Non-Obstructive Azoospermia Et klinisk interventionsforsøg
This study looks at new treatments for men with a specific type of male infertility where no sperm are found when ejaculating. It aims to see if certain new medicines can help these men produce sperm that could lead to a pregnancy, improving their chances of having a family.
For: Male infertilityDenmark - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Randomized, Double-blind, Parallel-group, Active-controlled Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of MAB-22 Versus Prolia® Sourced from the European Union in Postmenopausal Women with Osteoporosis
This study compares a new medicine called MAB-22 with an existing one, Prolia, for postmenopausal women with osteoporosis. It checks how well they build bone, how the body handles them, and if they are safe. It's to confirm if MAB-22 is a good alternative.
For: OsteoporosisCzechia · Bulgaria · Poland - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A randomized, double-blind, parallel-group, active-controlled comparative study to evaluate the efficacy, safety, pharmacokinetics, and immunogenicity of LY06006 compared with EU-Prolia in postmenopausal women with osteoporosis
This study is looking at a new medicine called LY06006 for women after menopause who have osteoporosis. It compares this new medicine to an existing one called Prolia to see if it works as well and is safe. The aim is to help make bones stronger.
For: Postmenopausal osteoporosisCzechia · Bulgaria · Poland - Ongoing, recruitingTherapeutic use (Phase IV)
Treatment of Osteogenesis Imperfecta with Parathyroid hormone and Zoledronic acid
This study looks at different treatments for Osteogenesis Imperfecta (brittle bone disease) in adults. Researchers want to understand which treatments best reduce bone breaks over several years. It's an ongoing study tracking real-world results.
For: Osteogenesis imperfectaFrance · Ireland · Netherlands - AuthorisedTherapeutic use (Phase IV)
Effect of Romosozumab vs. Denosumab on Coronary Atherosclerotic Damage in Postmenopausal Osteoporotic Women: A Phase IV, Low-Risk, Pharmacological Intervention Study. ATRIO Study.
This study looks at how two common osteoporosis medicines, Evenity and Prolia, affect the heart and blood vessels in postmenopausal women. Researchers want to see if these treatments change the amount of hardening in the arteries around the heart over 12 months.
For: Coronary atherosclerotic status in women with postmenopausal osteoporosisItaly